BlackRock Inc. - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$209,771
+25.5%
110,990
-2.4%
0.00%
Q2 2023$167,126
-35.0%
113,691
-13.8%
0.00%
Q1 2023$257,279
-18.7%
131,938
-6.2%
0.00%
Q4 2022$316,396
-6.4%
140,620
+0.2%
0.00%
Q3 2022$338,000
+15.8%
140,350
+0.1%
0.00%
Q2 2022$292,000
-25.5%
140,248
+1.0%
0.00%
Q1 2022$392,000
-39.0%
138,902
+0.8%
0.00%
Q4 2021$643,000
-27.9%
137,733
-58.6%
0.00%
Q3 2021$892,000
-20.9%
333,051
-15.9%
0.00%
Q2 2021$1,127,000
+2.3%
396,024
+9.0%
0.00%
Q1 2021$1,102,000
+3.0%
363,445
+0.3%
0.00%
Q4 2020$1,070,000
-8.6%
362,411
-0.7%
0.00%
Q3 2020$1,171,000
-1.6%
364,974
+2.1%
0.00%
Q2 2020$1,190,000
+0.1%
357,420
+9.1%
0.00%
Q1 2020$1,189,000
-30.4%
327,615
-1.2%
0.00%
Q4 2019$1,708,000
-13.3%
331,559
-0.2%
0.00%
Q3 2019$1,969,000
-7.0%
332,156
-0.1%
0.00%
Q2 2019$2,118,000
+28.4%
332,543
+17.2%
0.00%
Q1 2019$1,650,000
-10.9%
283,790
-7.5%
0.00%
Q4 2018$1,851,000
+2.5%
306,901
-3.0%
0.00%
Q3 2018$1,805,000
-10.8%
316,232
-4.3%
0.00%
Q2 2018$2,024,000
-8.9%
330,318
-0.7%
0.00%
Q1 2018$2,221,000
-20.0%
332,482
-11.9%
0.00%
Q4 2017$2,777,000
-0.1%
377,217
-4.2%
0.00%
Q3 2017$2,781,000
-0.8%
393,890
-1.6%
0.00%
Q2 2017$2,803,000
-3.5%
400,445
-4.3%
0.00%
Q1 2017$2,904,000418,6270.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q2 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders